,Set,NGenes,Direction,PValue,FDR
1,WP_PROSTAGLANDIN_SIGNALING,24,Down,1.16209530180255e-06,0.0009587286239871
2,WP_SPINAL_CORD_INJURY,64,Down,6.21768057638542e-06,0.00256479323775899
3,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,1.85553640556266e-05,0.00418739276371519
4,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,2.03025103695282e-05,0.00418739276371519
5,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,3.40597475288492e-05,0.00561985834226012
6,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,1,Down,4.82429800392345e-05,0.00595785435468522
7,WP_POSTCOVID_NEUROINFLAMMATION,13,Down,5.05514914942989e-05,0.00595785435468522
8,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,41,Down,0.000143261566531933,0.0143542160611931
9,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Down,0.00022077101009906,0.0143542160611931
10,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,28,Down,0.000227378708029201,0.0143542160611931
11,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,10,Down,0.000228521363781598,0.0143542160611931
12,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Down,0.000247600053408287,0.0143542160611931
13,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,26,Down,0.000249138589049243,0.0143542160611931
14,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,93,Down,0.000296972305329467,0.0143542160611931
15,WP_PURINERGIC_SIGNALING,16,Down,0.000298595085794577,0.0143542160611931
16,WP_HYPERTROPHY_MODEL,13,Down,0.000311710961516516,0.0143542160611931
17,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,8,Down,0.000328030989050258,0.0143542160611931
18,WP_GPCRS_CLASS_A_RHODOPSINLIKE,47,Down,0.000329192372280732,0.0143542160611931
19,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,5,Down,0.000342724005161152,0.0143542160611931
20,WP_CCL18_SIGNALING,23,Down,0.000348191266485905,0.0143542160611931
21,WP_PRION_DISEASE_PATHWAY,29,Down,0.000385924328723367,0.0143542160611931
22,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,75,Down,0.000387990725434784,0.0143542160611931
23,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.000400178144736294,0.0143542160611931
24,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,27,Down,0.000444406286253973,0.0152764660899803
25,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,26,Down,0.00050663045254875,0.0159857370350833
26,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.000524599431051213,0.0159857370350833
27,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,12,Down,0.000533360907229402,0.0159857370350833
28,WP_MAPK_SIGNALING,157,Down,0.000542546226645252,0.0159857370350833
29,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.000643489301885351,0.0183061611743246
30,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Down,0.000754032437202574,0.0205199754846297
31,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.000846900249734787,0.0205199754846297
32,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.000851233752413765,0.0205199754846297
33,WP_BURN_WOUND_HEALING,62,Down,0.000860032175806091,0.0205199754846297
34,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,76,Down,0.000871895745829678,0.0205199754846297
35,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,53,Down,0.000893522702716051,0.0205199754846297
36,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Down,0.000911425983528871,0.0205199754846297
37,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,62,Down,0.000943460803661841,0.0205199754846297
38,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,25,Down,0.000945162507170823,0.0205199754846297
39,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,16,Down,0.00105448185650069,0.0221364321256715
40,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,28,Down,0.00107360089596015,0.0221364321256715
41,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.00115185666246188,0.0221364321256715
42,WP_EBOLA_VIRUS_INFECTION_IN_HOST,108,Down,0.00117055589652973,0.0221364321256715
43,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,47,Down,0.00121374826176864,0.0221364321256715
44,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,13,Down,0.00124102349755881,0.0221364321256715
45,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.00124274199150597,0.0221364321256715
46,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.00124274199150597,0.0221364321256715
47,WP_IL26_SIGNALING,33,Down,0.00127423944749649,0.0221364321256715
48,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Down,0.00128793786912998,0.0221364321256715
49,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.00139608755410398,0.0235055557578731
50,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,27,Down,0.00167288250743807,0.0270963544440457
51,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,19,Down,0.00167504736563191,0.0270963544440457
52,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.00172384095330372,0.0273493997399148
53,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,8,Down,0.00176526586410725,0.0274781950544996
54,WP_GASTRIN_SIGNALING,91,Down,0.00194006471666378,0.0296398776156966
55,WP_CHEMOKINE_SIGNALING,114,Down,0.00206315212917308,0.0304745484042679
56,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.00206857540683516,0.0304745484042679
57,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,11,Down,0.0021250262015331,0.0307569581800844
58,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.00221819304574407,0.0315518838403251
59,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Down,0.00267697817600408,0.0374323219525995
60,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,11,Down,0.00292164276397846,0.0401725880047038
61,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.00303703811314796,0.0410746957925748
62,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.00309123123170405,0.0411333188089652
63,WP_VEGFAVEGFR2_SIGNALING,338,Down,0.0031849142442956,0.0417072103419662
64,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Down,0.00344736731653364,0.0444387193146914
65,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.00359265554691087,0.044774065120346
66,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,76,Down,0.00361754200819268,0.044774065120346
67,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.00363619680371295,0.044774065120346
68,WP_PLEURAL_MESOTHELIOMA,246,Down,0.00373785483135065,0.0453489740568278
69,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,18,Down,0.00380448282795388,0.045488381638579
70,WP_MICROTUBULE_CYTOSKELETON_REGULATION,34,Down,0.00404550647446341,0.0476791834490331
71,WP_VITAMIN_D_RECEPTOR_PATHWAY,82,Down,0.00414055687176017,0.0481121044958048
72,WP_LUNG_PATHOLOGY_OF_COVID19,16,Down,0.00431622350530428,0.0493170275102072
73,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Down,0.00436380970696378,0.0493170275102072
74,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Down,0.00449588324948585,0.0501230227138625
75,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.00497292407771886,0.0545043259392334
76,WP_LUNG_FIBROSIS,35,Down,0.00516851754334521,0.0545043259392334
77,WP_BLADDER_CANCER,30,Down,0.0051782315360136,0.0545043259392334
78,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.00522453060558802,0.0545043259392334
79,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Down,0.00527488425120488,0.0545043259392334
80,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,15,Down,0.00537294469660287,0.0545043259392334
81,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,6,Down,0.00537811172556402,0.0545043259392334
82,WP_AGERAGE_PATHWAY,55,Down,0.00541739966911168,0.0545043259392334
83,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.00557355878465544,0.0553998312932619
84,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,6,Up,0.0056515507214921,0.0555063017289403
85,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.00683200384240075,0.0655863991922261
86,WP_COMPLEMENT_ACTIVATION,11,Up,0.00683688524912903,0.0655863991922261
87,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.00713114078210358,0.0673328064287768
88,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,51,Down,0.00718216601906952,0.0673328064287768
89,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.0073065555871433,0.0677293074089126
90,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Down,0.00746038565394895,0.0682098776641625
91,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.0075237562029561,0.0682098776641625
92,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.00761599394115562,0.0682955978418846
93,WP_HIPPO_SIGNALING_REGULATION,41,Down,0.0078749212897802,0.0698581727319212
94,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Down,0.00798059375589568,0.0700424451980206
95,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Down,0.00815628018078245,0.0708308542015318
96,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,11,Down,0.00828086965417742,0.0711637235905872
97,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.00876442028409407,0.073951753670445
98,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.00878457195115589,0.073951753670445
99,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,16,Down,0.00899382939032219,0.0742328060387521
100,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.0089979158834851,0.0742328060387521
101,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Up,0.00938662984922951,0.0760729557970402
102,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Down,0.00940538362581589,0.0760729557970402
103,WP_PDGF_PATHWAY,36,Down,0.00956469529631721,0.0766104234899194
104,WP_MEVALONATE_PATHWAY,7,Down,0.0103978058577864,0.0819061166168285
105,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.0104244148421418,0.0819061166168285
106,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,40,Down,0.0106851963585227,0.0831630848658605
107,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.0109396078475046,0.0843474436840311
108,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.0110742815498371,0.0845952062834782
109,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.0115225980022165,0.0869029645538395
110,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.0115870619405119,0.0869029645538395
111,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Down,0.0118580161673574,0.0870219758941471
112,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.0119834384172146,0.0870219758941471
113,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,74,Down,0.0121413392691094,0.0870219758941471
114,WP_SEROTONIN_AND_ANXIETY,6,Down,0.012257317904292,0.0870219758941471
115,WP_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.0122706906545196,0.0870219758941471
116,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.0122706906545196,0.0870219758941471
117,WP_PEPTIDE_GPCRS,14,Down,0.0123440115316931,0.0870219758941471
118,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,34,Down,0.0124467795824356,0.0870219758941471
119,WP_EGFEGFR_SIGNALING,138,Down,0.0128417998759442,0.0883387453932326
120,WP_HEART_DEVELOPMENT,15,Down,0.0128492720571975,0.0883387453932326
121,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.013181522892913,0.0893544480320377
122,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.0132136274665559,0.0893544480320377
123,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.0134469864693095,0.0901932019282951
124,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,133,Down,0.0137048834218194,0.0911816840564599
125,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,12,Down,0.0141547155165327,0.0933861836728398
126,WP_SMALL_LIGAND_GPCRS,7,Down,0.014262617142761,0.0933861836728398
127,WP_ASPIRIN_AND_MIRNAS,8,Down,0.0144267351689692,0.0936486424752163
128,WP_RETINOL_METABOLISM,5,Down,0.0145786201146861,0.0936486424752163
129,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.0146432422779429,0.0936486424752163
130,WP_OREXIN_RECEPTOR_PATHWAY,112,Down,0.0151237808798798,0.0959729724894799
131,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,9,Down,0.015239344722572,0.0959729724894799
132,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.015535415039946,0.0970963439996627
133,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.016142467015963,0.100131844271951
134,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.0163715933058613,0.100795257293549
135,WP_NETRINUNC5B_SIGNALING,35,Down,0.0166692767634214,0.101867802443131
136,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.0170852453297128,0.103642113213331
137,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.0173523798822783,0.104494258415179
138,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,95,Down,0.0178404628824888,0.106015921885705
139,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Down,0.0178620765358946,0.106015921885705
140,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.018581934777089,0.109500687079275
141,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.0187156578837978,0.109506508894562
142,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.0194764547596679,0.113155458991028
143,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.0199744090044596,0.115149777607535
144,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Down,0.0200988702733152,0.115149777607535
145,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.0204891906720186,0.116576429685623
146,WP_PROTEASOME_DEGRADATION,57,Down,0.0207433244577614,0.116692155680835
147,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,11,Up,0.0210735791296036,0.116692155680835
148,WP_ONCOSTATIN_M_SIGNALING,56,Down,0.0210842546708208,0.116692155680835
149,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.0211886122348436,0.116692155680835
150,WP_IRINOTECAN_PATHWAY,5,Up,0.0212167555783337,0.116692155680835
151,WP_NEURAL_CREST_DIFFERENTIATION,34,Down,0.021524614217864,0.117601369071111
152,WP_IL19_SIGNALING,20,Down,0.0236870348388245,0.127893176541202
153,WP_ERBB_SIGNALING,68,Down,0.0237595963757775,0.127893176541202
154,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,71,Down,0.0238733929543577,0.127893176541202
155,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.0243310744083799,0.129504105722022
156,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.0245612852219275,0.129891412231347
157,WP_ESTROGEN_METABOLISM_WP5276,9,Up,0.0248071912890461,0.130356259958364
158,WP_IL18_SIGNALING,190,Down,0.0251376336255427,0.130620658383066
159,WP_IL1_SIGNALING,51,Down,0.0251741632520091,0.130620658383066
160,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Down,0.0260403152745686,0.134270375634494
161,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.026405429164893,0.135307323360476
162,WP_PREIMPLANTATION_EMBRYO,20,Down,0.0267068133654499,0.135848435264201
163,WP_ENDODERM_DIFFERENTIATION,82,Down,0.0268403575128058,0.135848435264201
164,WP_TP53_NETWORK,14,Down,0.0273264821867121,0.137129633869025
165,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.0274477234774836,0.137129633869025
166,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Down,0.0276883527632938,0.137129633869025
167,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Down,0.0277583622498512,0.137129633869025
168,WP_G_PROTEIN_SIGNALING,60,Down,0.0285570325411923,0.139433892692793
169,WP_ULCERATIVE_COLITIS_SIGNALING,13,Down,0.0287441030678354,0.139433892692793
170,WP_NUCLEOTIDE_GPCRS,7,Down,0.028885389176851,0.139433892692793
171,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.028900843212688,0.139433892692793
172,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,39,Down,0.0293837474292134,0.140803766848796
173,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.0295671793235055,0.140803766848796
174,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.0298472555848984,0.140803766848796
175,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.0299202131495132,0.140803766848796
176,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Up,0.0300381369277431,0.140803766848796
177,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Down,0.0308012113668012,0.142955444460027
178,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,76,Down,0.0308437201380422,0.142955444460027
179,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.0325010990911447,0.14979556843684
180,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,10,Up,0.0332795207802387,0.150618856741382
181,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.0333235180587886,0.150618856741382
182,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,25,Down,0.0336059701346571,0.150618856741382
183,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.0337662883306001,0.150618856741382
184,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.0338698460483084,0.150618856741382
185,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,11,Down,0.0339542079719455,0.150618856741382
186,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.0339577058835116,0.150618856741382
187,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.0351545585457532,0.154155906126926
188,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.035277545172067,0.154155906126926
189,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.0354479511560696,0.154155906126926
190,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.0355025723201404,0.154155906126926
191,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Down,0.0358240598686541,0.154737431369841
192,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.0361699954747329,0.154978288840626
193,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.036528903132265,0.154978288840626
194,WP_RAS_SIGNALING,113,Down,0.0366082167295078,0.154978288840626
195,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.0366538418609165,0.154978288840626
196,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Down,0.0368190843791063,0.154978288840626
197,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.0372134476852719,0.15584311847893
198,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Down,0.038605395095602,0.159898026846751
199,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,55,Down,0.0389444177677064,0.159898026846751
200,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.0391272985021275,0.159898026846751
201,WP_INTEGRINMEDIATED_CELL_ADHESION,70,Down,0.0391812661821153,0.159898026846751
202,WP_PPAR_SIGNALING,37,Up,0.0393227007133377,0.159898026846751
203,WP_MELANOMA,53,Down,0.0393446053938065,0.159898026846751
204,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.041204829603933,0.166637178545317
205,WP_SYNAPTIC_VESICLE_PATHWAY,20,Down,0.0417594081714124,0.167767916503646
206,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.0418911403633346,0.167767916503646
207,WP_ALLOGRAFT_REJECTION,50,Down,0.0422817997678984,0.168514419364812
208,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Down,0.0428801783383175,0.170077630428423
209,WP_JOUBERT_SYNDROME,66,Up,0.0438252146509692,0.172984871454107
210,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.0440325127337726,0.172984871454107
211,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.0442724719490712,0.173055747753959
212,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.0444700830591991,0.173055747753959
213,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.046578814082608,0.180410899615735
214,WP_HEPATITIS_B_INFECTION,118,Down,0.0478094859126588,0.18431227045768
215,WP_RAC1PAK1P38MMP2_PATHWAY,52,Down,0.0482121949368395,0.185000282897175
216,WP_PROLACTIN_SIGNALING,70,Down,0.0492427408472799,0.187416971536141
217,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0495787045476766,0.187416971536141
218,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Down,0.0496803545355476,0.187416971536141
219,WP_CELL_CYCLE,87,Down,0.0501347997156024,0.187416971536141
220,WP_TRANSLATION_FACTORS,49,Down,0.0501655484321532,0.187416971536141
221,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,15,Up,0.0502283869209742,0.187416971536141
222,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Down,0.0505786065532927,0.187416971536141
223,WP_UROTENSINIIMEDIATED_SIGNALING,48,Down,0.0506593753364356,0.187416971536141
224,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.0517101423895996,0.190450301211695
225,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.0529670159215016,0.194212391712173
226,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.0545574350611551,0.199158778431208
227,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Down,0.0550921130861929,0.200224640070966
228,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Down,0.0554259030285177,0.200554254379505
229,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.0558647873920136,0.201259605233237
230,WP_IL7_SIGNALING,24,Down,0.0563238684179045,0.202031267151179
231,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.0570715507386717,0.203826966923828
232,WP_ACUTE_VIRAL_MYOCARDITIS,66,Down,0.0579297054105107,0.205803695465145
233,WP_FOCAL_ADHESION,117,Down,0.0582626043080852,0.205803695465145
234,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,61,Up,0.0583734118046592,0.205803695465145
235,WP_GLIOBLASTOMA_SIGNALING,65,Down,0.0592785265841164,0.208105465667643
236,WP_NEOVASCULARIZATION_PROCESSES,23,Down,0.0598160595706789,0.209102750617839
237,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Down,0.0602626544024889,0.209775062793474
238,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,8,Up,0.06117103612575,0.212042457158587
239,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.0618542052592347,0.21290640040573
240,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.0620805952061753,0.21290640040573
241,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.0621990489956568,0.21290640040573
242,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Down,0.0624525441190141,0.21290640040573
243,WP_CYTOSINE_METHYLATION,7,Down,0.0633834602700267,0.215190760176016
244,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,1,Down,0.0640443503029973,0.216543397540872
245,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.0647217852416605,0.217151427324902
246,WP_HUNGER_AND_SATIETY,2,Up,0.0647506074205162,0.217151427324902
247,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.0652871225989668,0.218064275887237
248,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.065949992746409,0.219390096837852
249,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.0673720749721789,0.223220730329508
250,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Down,0.0681363858053101,0.224070607074578
251,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,12,Down,0.0684423411375889,0.224070607074578
252,WP_IL5_SIGNALING,37,Down,0.0684433854336894,0.224070607074578
253,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,51,Down,0.0689927218365313,0.224976266858254
254,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,27,Down,0.0692814581777011,0.225028358254344
255,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,7,Up,0.0722215584849296,0.232745256836199
256,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,7,Up,0.0722215584849296,0.232745256836199
257,WP_GPCRS_OTHER,13,Down,0.0736787252696915,0.236517308745119
258,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.0745151636091786,0.237382189839638
259,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Down,0.0745236208102621,0.237382189839638
260,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,62,Down,0.0755729858069393,0.239237470097397
261,WP_PTF1A_RELATED_REGULATORY_PATHWAY,4,Down,0.0758231102150405,0.239237470097397
262,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Down,0.0759760208066886,0.239237470097397
263,WP_WNT_SIGNALING_WP428,58,Down,0.0769965546187245,0.240800926378523
264,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Down,0.0770562964411274,0.240800926378523
265,WP_BREAST_CANCER_PATHWAY,82,Down,0.0785217860673587,0.244099307371728
266,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.0787035342556116,0.244099307371728
267,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Down,0.0802560209733323,0.247141727837799
268,WP_CANCER_PATHWAYS,292,Down,0.0802975172095179,0.247141727837799
269,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.080583181561658,0.247141727837799
270,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,17,Down,0.0810555438940239,0.247669717453962
271,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.0822784764823478,0.250478756818955
272,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,8,Down,0.08296150328779,0.25162955960451
273,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.0835482072196644,0.252480845993491
274,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,18,Down,0.085702031348054,0.258044437453082
275,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.0878333464547983,0.263500039364395
276,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,120,Down,0.088498175024082,0.263830863109609
277,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,82,Down,0.088583211007711,0.263830863109609
278,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.0892393606741058,0.264105756468491
279,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.0893157649147989,0.264105756468491
280,WP_OSTEOPONTIN_SIGNALING,12,Down,0.0911377377134947,0.268299970294403
281,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.0919739614404922,0.268299970294403
282,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.0921288947870067,0.268299970294403
283,WP_TRYPTOPHAN_METABOLISM,17,Up,0.0921381478624165,0.268299970294403
284,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.0923798216170497,0.268299970294403
285,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Down,0.092685444283521,0.268299970294403
286,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.0974563281063936,0.281124023383828
287,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.0980198318021092,0.28176432486669
288,WP_LEPTIN_SIGNALING,70,Down,0.0997931464142123,0.28298532734857
289,WP_RANKLRANK_SIGNALING,47,Down,0.10010164739674,0.28298532734857
290,WP_IL2_SIGNALING,37,Down,0.100246678722467,0.28298532734857
291,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,5,Up,0.100379287398464,0.28298532734857
292,WP_SMALL_CELL_LUNG_CANCER,64,Down,0.100402522264091,0.28298532734857
293,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Down,0.100502667773492,0.28298532734857
294,WP_BARDETBIEDL_SYNDROME,61,Up,0.100961065819919,0.283309113270181
295,WP_ATR_SIGNALING,10,Up,0.101965399820181,0.285157474073389
296,WP_MONOAMINE_TRANSPORT,11,Down,0.102423683107837,0.285471414067451
297,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Down,0.103257966062585,0.286343363290115
298,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.103430693649035,0.286343363290115
299,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Down,0.104037590922766,0.287060242512648
300,WP_16P112_DISTAL_DELETION_SYNDROME,21,Up,0.106077141260494,0.291645564336205
301,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Down,0.106406442260846,0.291645564336205
302,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Down,0.109235218785318,0.298407468536052
303,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,49,Down,0.109713276749608,0.298724268377645
304,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,54,Up,0.110165550516905,0.298913719317197
305,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.11093014559727,0.298913719317197
306,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.111245342978856,0.298913719317197
307,WP_VITAMIN_A1_AND_A5X_PATHWAYS,4,Down,0.111311186964788,0.298913719317197
308,WP_DOPAMINE_METABOLISM,7,Down,0.111755899738686,0.298913719317197
309,WP_PI3KAKT_SIGNALING,174,Down,0.112052984918845,0.298913719317197
310,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Up,0.11231909453131,0.298913719317197
311,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,61,Down,0.113301948902048,0.299903806341369
312,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,81,Down,0.113561903200639,0.299903806341369
313,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.113781686527089,0.299903806341369
314,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.114823561695456,0.300947141272507
315,WP_SILDENAFIL_TREATMENT,11,Down,0.115181583490265,0.300947141272507
316,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.115271874717712,0.300947141272507
317,WP_ATM_SIGNALING,32,Down,0.117994093657163,0.307082420401134
318,WP_WNT_SIGNALING_AND_PLURIPOTENCY,58,Down,0.121639765472786,0.315574863254869
319,WP_REGULATION_OF_ACTIN_CYTOSKELETON,88,Down,0.122600807085031,0.316117709379747
320,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,39,Down,0.122615353941235,0.316117709379747
321,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.123759521329042,0.318073536126043
322,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,13,Up,0.124906249227136,0.318772964873626
323,WP_MRNA_PROCESSING,124,Down,0.125909657450645,0.318772964873626
324,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.126159470665628,0.318772964873626
325,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,35,Down,0.126310654635397,0.318772964873626
326,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.12638106753961,0.318772964873626
327,WP_PHOSPHOINOSITIDES_METABOLISM,37,Up,0.126578481899984,0.318772964873626
328,WP_MONOAMINE_GPCRS,4,Down,0.126858889559435,0.318772964873626
329,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,10,Down,0.127122794476876,0.318772964873626
330,WP_ALZHEIMERS_DISEASE,183,Down,0.132086780032555,0.32839693888211
331,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,183,Down,0.132086780032555,0.32839693888211
332,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,43,Down,0.132458306978973,0.32839693888211
333,WP_THERMOGENESIS,75,Down,0.132552946239688,0.32839693888211
334,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.133312360841807,0.329289514055361
335,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.133867342063199,0.329673305081011
336,WP_TGFBETA_RECEPTOR_SIGNALING,34,Down,0.13525951640141,0.332110419735604
337,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.136356150862947,0.333809568136295
338,WP_DISORDERS_IN_KETOLYSIS,3,Down,0.137560957038,0.334228011099044
339,WP_WNT_SIGNALING_WP363,40,Down,0.137960237216047,0.334228011099044
340,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,8,Down,0.138274553649209,0.334228011099044
341,WP_VITAMIN_B12_METABOLISM,24,Down,0.138521370978366,0.334228011099044
342,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.138552702782877,0.334228011099044
343,WP_OSTEOBLAST_SIGNALING,2,Down,0.141021189880207,0.339190908603997
344,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.143088770486166,0.343163475729904
345,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.144270084193427,0.343786255281228
346,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.14478511717249,0.343786255281228
347,WP_PURINE_METABOLISM,10,Down,0.144859577793218,0.343786255281228
348,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.14535336168995,0.343786255281228
349,WP_CAMKK2_PATHWAY,29,Down,0.145432003749271,0.343786255281228
350,WP_ENDOTHELIN_PATHWAYS,12,Down,0.145887571087793,0.343877846135512
351,WP_DNA_DAMAGE_RESPONSE,56,Down,0.147046285757869,0.344822065525759
352,WP_15Q25_COPY_NUMBER_VARIATION,26,Up,0.14712408129099,0.344822065525759
353,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.149907055222018,0.350133992865151
354,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.15051782124701,0.350133992865151
355,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.150663718141974,0.350133992865151
356,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,26,Down,0.151405192229573,0.350868774127522
357,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.153042498184862,0.352264851899426
358,WP_METABOLIC_EPILEPTIC_DISORDERS,57,Down,0.153076855183382,0.352264851899426
359,WP_DRAVET_SYNDROME,12,Down,0.153288584038659,0.352264851899426
360,WP_B_CELL_RECEPTOR_SIGNALING,87,Down,0.15381544310935,0.352354756140473
361,WP_GASTRIC_CANCER_NETWORK_1,16,Up,0.154181899353589,0.352354756140473
362,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.154944062077881,0.352747601903615
363,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,5,Up,0.15520894483759,0.352747601903615
364,WP_TNFALPHA_SIGNALING,81,Down,0.158118173885877,0.357856983388235
365,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.158324604771765,0.357856983388235
366,WP_MAPK_CASCADE,30,Down,0.159961665079927,0.360569327024426
367,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.161062188579419,0.362060778141746
368,WP_SULINDAC_METABOLIC_PATHWAY,3,Up,0.161969997829994,0.362201447935818
369,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.162064954797523,0.362201447935818
370,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Down,0.162443785115715,0.362201447935818
371,WP_MATRIX_METALLOPROTEINASES,10,Down,0.162880893556592,0.362201447935818
372,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,13,Down,0.163609340870593,0.362831996770381
373,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,33,Down,0.164044042176184,0.362831996770381
374,WP_AXON_GUIDANCE,33,Down,0.165611328558097,0.36531910711345
375,WP_OVARIAN_INFERTILITY,21,Down,0.168925070131825,0.370714892233283
376,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,80,Up,0.168956120581472,0.370714892233283
377,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.170678049713051,0.373499710910523
378,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,60,Down,0.1738206874311,0.378051515306451
379,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.174046129624097,0.378051515306451
380,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,22,Down,0.174132819171456,0.378051515306451
381,WP_ENDOMETRIAL_CANCER,48,Down,0.175890104148081,0.380514890702023
382,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.1761899251493,0.380514890702023
383,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.177954206605594,0.382151608849596
384,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,57,Down,0.178039875369369,0.382151608849596
385,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.178337417463145,0.382151608849596
386,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.178826228087867,0.382206316509042
387,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.180230260250262,0.384211795107148
388,WP_10Q22Q23_COPY_NUMBER_VARIATION,26,Down,0.181763160743732,0.386480947457678
389,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,36,Up,0.185378937987868,0.393155845347021
390,WP_CILIOPATHIES,114,Up,0.18768450568343,0.397024915868793
391,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.188282960450242,0.397272231129027
392,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,16,Down,0.190041683482554,0.399960175696701
393,WP_13Q1212_COPY_NUMBER_VARIATION,17,Down,0.190657245635179,0.400234675951711
394,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.194013078200793,0.406245658669172
395,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,20,Down,0.195492264829257,0.408306629073765
396,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Down,0.196732997690338,0.408309292875947
397,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,58,Down,0.196837918893288,0.408309292875947
398,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.196978301290457,0.408309292875947
399,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.198518028425584,0.410469607646885
400,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.199099704726929,0.410643140999291
401,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,27,Down,0.199664102549222,0.410780260855632
402,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,3,Up,0.200434205549466,0.411337289103043
403,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.20141920665426,0.411337289103043
404,WP_NOTCH_SIGNALING_WP61,48,Down,0.201430623997126,0.411337289103043
405,WP_IL17_SIGNALING,24,Down,0.203947010011663,0.414558489682658
406,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.204412148311151,0.414558489682658
407,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,41,Down,0.204515521576778,0.414558489682658
408,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.209679872742397,0.423985036795287
409,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.210229903042828,0.4240578728859
410,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,11,Up,0.212076901951585,0.426740107585506
411,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,23,Down,0.214268915114364,0.430101836908395
412,WP_NUCLEAR_RECEPTORS_METAPATHWAY,174,Down,0.216467912538974,0.432639334711315
413,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Up,0.217010151084513,0.432639334711315
414,WP_TCELL_ACTIVATION_SARSCOV2,60,Down,0.21710628432786,0.432639334711315
415,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Up,0.218356981148247,0.434083155294707
416,WP_TAR_SYNDROME,44,Down,0.219117725981529,0.434548374843177
417,WP_DNA_MISMATCH_REPAIR,21,Up,0.223008641438127,0.439806356110896
418,WP_AEROBIC_GLYCOLYSIS,9,Down,0.22340041023205,0.439806356110896
419,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,9,Down,0.22340041023205,0.439806356110896
420,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Up,0.22444140033255,0.439806356110896
421,WP_MACROPHAGE_MARKERS,8,Up,0.224503752145017,0.439806356110896
422,WP_15Q11Q13_COPY_NUMBER_VARIATION,28,Up,0.224967614883391,0.439806356110896
423,WP_G13_SIGNALING,30,Down,0.227620508362519,0.443940707799239
424,WP_TYPE_II_INTERFERON_SIGNALING,31,Down,0.228398836332358,0.444142038929693
425,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Down,0.229114686475531,0.444142038929693
426,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Down,0.229338798283696,0.444142038929693
427,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,39,Down,0.232737622514539,0.449281957072301
428,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.233082033487206,0.449281957072301
429,WP_LIPID_PARTICLES_COMPOSITION,4,Up,0.23372038217463,0.449462273412751
430,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.236205431268329,0.453184839061328
431,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.237814250254277,0.455212892018047
432,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Down,0.239554461854646,0.457482479236304
433,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.243574859205778,0.460045395274749
434,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.243743646926554,0.460045395274749
435,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,24,Down,0.243774254345315,0.460045395274749
436,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.243840999002571,0.460045395274749
437,WP_APOPTOSIS_MODULATION_AND_SIGNALING,73,Down,0.244081302580952,0.460045395274749
438,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Down,0.24424228258223,0.460045395274749
439,WP_GLUCURONIDATION,7,Up,0.245652005017829,0.461551530396048
440,WP_NEUROINFLAMMATION,10,Down,0.246160816211226,0.461551530396048
441,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Up,0.246897571508922,0.461883212006486
442,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,11,Down,0.24968502588625,0.466041055104425
443,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.25084313799984,0.467145798758167
444,WP_MINERALOCORTICOID_BIOSYNTHESIS,2,Up,0.257270773557341,0.477175591485317
445,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.257385622073898,0.477175591485317
446,WP_KIT_RECEPTOR_SIGNALING,51,Down,0.261639891165235,0.483975135002957
447,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,9,Down,0.262697071214259,0.484843587811551
448,WP_IL11_SIGNALING,39,Down,0.264051375056265,0.486255322369239
449,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.26500257093373,0.486920091359304
450,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.267148738105655,0.489772686527033
451,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.269933570849069,0.492168974710064
452,WP_INSULIN_SIGNALING,126,Down,0.27015833123761,0.492168974710064
453,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.270245509749889,0.492168974710064
454,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.27476375130348,0.499295363051477
455,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,46,Down,0.275387363536214,0.499328736082147
456,WP_NAD_METABOLISM,11,Down,0.277077609760671,0.500385641699187
457,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.277183319098822,0.500385641699187
458,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,28,Down,0.27998012477519,0.503729062939826
459,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.280256533199248,0.503729062939826
460,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,14,Up,0.281898707807823,0.505579204220551
461,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.283118780438058,0.506665930285027
462,WP_TAMOXIFEN_METABOLISM,3,Up,0.284668516717936,0.508336636996315
463,WP_ESTROGEN_SIGNALING,21,Down,0.288570153678278,0.514190878584405
464,WP_NOTCH_SIGNALING_WP268,33,Down,0.294104477419581,0.522922831618867
465,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.297011112239529,0.524238979913409
466,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,65,Down,0.297223985950298,0.524238979913409
467,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Down,0.297308622041843,0.524238979913409
468,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Down,0.297386475878152,0.524238979913409
469,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,17,Down,0.300227324237842,0.528118427497271
470,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.301598162838069,0.529401030513632
471,WP_CREATINE_PATHWAY,2,Down,0.302746628267751,0.530288680086825
472,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,63,Down,0.304368047376765,0.531999235351338
473,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.308623627797045,0.538297025227405
474,WP_IL3_SIGNALING,45,Down,0.309901111296004,0.539384845610133
475,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,80,Down,0.312284848672817,0.539851018672616
476,WP_ID_SIGNALING,11,Down,0.312545319448948,0.539851018672616
477,WP_SERINE_METABOLISM,7,Down,0.312600652387988,0.539851018672616
478,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,17,Down,0.312793669772334,0.539851018672616
479,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.313785932437392,0.539851018672616
480,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Down,0.314687921132772,0.539851018672616
481,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.314749503007913,0.539851018672616
482,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,23,Down,0.317845872003305,0.54403079751603
483,WP_KREBS_CYCLE_DISORDERS,11,Up,0.324745711814231,0.553659803301237
484,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Down,0.324813751270059,0.553659803301237
485,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,20,Up,0.326460867269843,0.555320031953856
486,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.32913615808089,0.558718786865708
487,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Down,0.332106364171328,0.562603183657794
488,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.334199964356218,0.564989693839917
489,WP_VALPROIC_ACID_PATHWAY,8,Up,0.336427499359623,0.56759240689507
490,WP_GASTRIC_CANCER_NETWORK_2,25,Down,0.337524994290316,0.568281878141859
491,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,20,Down,0.340866525581952,0.571793625950562
492,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.340996926021426,0.571793625950562
493,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.342164942348471,0.572588392368131
494,WP_NRXN1_DELETION_SYNDROME,2,Up,0.346083506815131,0.577973467859277
495,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.349659172579875,0.582765287633125
496,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.350764478022994,0.583428819292279
497,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,49,Down,0.354098375058121,0.58778905316489
498,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,25,Down,0.358165699319803,0.592214267773622
499,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.35819990256853,0.592214267773622
500,WP_BLOOD_CLOTTING_CASCADE,6,Down,0.359408272354983,0.593023649385721
501,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.362789152989786,0.597407287857432
502,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.368010893520562,0.604798779192159
503,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.37438565212119,0.614052013916465
504,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,4,Down,0.377472047321911,0.617885791747175
505,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,68,Down,0.379296380784141,0.619642602271121
506,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Down,0.380341092849154,0.620121347036664
507,WP_COMPLEMENT_SYSTEM,52,Up,0.382718216133756,0.622107808804898
508,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,163,Down,0.383067596209562,0.622107808804898
509,WP_GALANIN_RECEPTOR_PATHWAY,11,Down,0.385003234549291,0.623201064576448
510,WP_SPHINGOLIPID_PATHWAY,21,Down,0.385797373980601,0.623201064576448
511,WP_IL4_SIGNALING,50,Down,0.386006962422503,0.623201064576448
512,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,24,Down,0.387318743895238,0.624097585378069
513,WP_P38_MAPK_SIGNALING,31,Down,0.388503186097698,0.624785825595713
514,WP_IDO_METABOLIC_PATHWAY,6,Up,0.391633540481428,0.628594690461436
515,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.394781788825404,0.630717318324542
516,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.395099316134853,0.630717318324542
517,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,33,Down,0.395249519483379,0.630717318324542
518,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.39692421874894,0.63153076233265
519,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Down,0.398651638397587,0.63153076233265
520,WP_FRAGILE_X_SYNDROME,83,Down,0.398926166039221,0.63153076233265
521,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.399370369112476,0.63153076233265
522,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.399586736894113,0.63153076233265
523,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,11,Down,0.400772583558223,0.632193845957044
524,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,22,Up,0.403829150105047,0.634618705932196
525,WP_ANGIOGENESIS,14,Down,0.403848267411397,0.634618705932196
526,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.40463735319576,0.634649841038977
527,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.407366201775451,0.637717488547907
528,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,13,Down,0.408610608599337,0.638454075936465
529,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Down,0.410283468201982,0.639856070447325
530,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.412412861473429,0.641963416444489
531,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.419195176727105,0.650138486318223
532,WP_ENERGY_METABOLISM,41,Down,0.419298708330335,0.650138486318223
533,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,15,Up,0.420028864494076,0.650138486318223
534,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Down,0.421157118748351,0.650664087953913
535,WP_FLUOROPYRIMIDINE_ACTIVITY,26,Down,0.422709008435239,0.651840994316022
536,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.431161772118179,0.663635190293839
537,WP_ARYLAMINE_METABOLISM,1,Up,0.432183565757147,0.66396916526936
538,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.434180894184781,0.665105165512915
539,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.437122420462297,0.665105165512915
540,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,50,Up,0.437507221022555,0.665105165512915
541,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Up,0.437899631242683,0.665105165512915
542,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Up,0.438237501228534,0.665105165512915
543,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.438397797507023,0.665105165512915
544,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,10,Up,0.438566315198819,0.665105165512915
545,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.441027900368097,0.667611041841614
546,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.441862435184222,0.667649283932203
547,WP_MESODERMAL_COMMITMENT_PATHWAY,74,Down,0.443574898688021,0.669011501677545
548,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.446000331821725,0.671442105388546
549,WP_HISTONE_MODIFICATIONS,35,Up,0.447415572179385,0.67200788160125
550,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,19,Down,0.448232396334491,0.67200788160125
551,WP_NONSMALL_CELL_LUNG_CANCER,58,Down,0.449194536981137,0.67200788160125
552,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,33,Down,0.450195636998873,0.67200788160125
553,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.450981103214952,0.67200788160125
554,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.451288792324955,0.67200788160125
555,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.452177088316529,0.67200788160125
556,WP_MALE_INFERTILITY,71,Down,0.452892584448842,0.67200788160125
557,WP_IRON_METABOLISM_IN_PLACENTA,9,Up,0.459522012732889,0.680620575412268
558,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.467648308007612,0.691415509151039
559,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,164,Down,0.468608790171138,0.691596157229318
560,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.469893703824467,0.692254117241402
561,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,38,Down,0.470909877446174,0.692514525656139
562,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Down,0.472407402812962,0.693480618008352
563,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,2,Up,0.473594496727944,0.693988383304713
564,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.475060947833585,0.694902982203382
565,WP_BDNFTRKB_SIGNALING,26,Down,0.47707503156658,0.696613984145891
566,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.481700402095268,0.700318535305132
567,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.481882289519617,0.700318535305132
568,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.482460279045034,0.700318535305132
569,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.483815726901953,0.700318535305132
570,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.484315281128928,0.700318535305132
571,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,112,Up,0.48470531352634,0.700318535305132
572,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.485621857904389,0.700416141208254
573,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.486836069435969,0.700941984790008
574,WP_DNA_REPLICATION,34,Up,0.487938121111099,0.701304790795569
575,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Down,0.49070858755621,0.703324138522951
576,WP_IL6_SIGNALING,39,Down,0.491048125805115,0.703324138522951
577,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.493860805848934,0.706126802123692
578,WP_APOPTOSIS,69,Down,0.503212463699994,0.718253084000856
579,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,46,Down,0.504939129075804,0.719472852310083
580,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.507136271360742,0.721357627366573
581,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Up,0.509600273977398,0.723614846869799
582,WP_PANCREATIC_CANCER_SUBTYPES,4,Down,0.516481686050934,0.730953328038259
583,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.516771049667109,0.730953328038259
584,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.517426355847689,0.730953328038259
585,WP_ACUTE_MYELOID_LEUKEMIA,56,Down,0.521922340132319,0.73604432582763
586,WP_NRF2ARE_REGULATION,21,Up,0.523602372352673,0.73715351056477
587,WP_NEPHROGENESIS,3,Down,0.526306456237305,0.739698171031988
588,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,10,Up,0.52857425103923,0.741622035896878
589,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,1,Down,0.530008735259765,0.74237216738422
590,WP_G1_TO_S_CELL_CYCLE_CONTROL,48,Down,0.531209570812462,0.74279304393268
591,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.53311938806619,0.742945093166566
592,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.53311938806619,0.742945093166566
593,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.53476580681586,0.74398278351279
594,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,44,Down,0.536451792999478,0.745071934721498
595,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.538122527459088,0.746136277569324
596,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.543126546062439,0.749649309966111
597,WP_ECTODERM_DIFFERENTIATION,72,Down,0.543151214771819,0.749649309966111
598,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,3,Down,0.543382166496648,0.749649309966111
599,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,54,Down,0.544724972524626,0.750247249303534
600,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.548727847726299,0.75223913228959
601,WP_GLUTATHIONE_METABOLISM,10,Up,0.548777861931621,0.75223913228959
602,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,26,Down,0.548906615319192,0.75223913228959
603,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.550219888189668,0.752788404239596
604,WP_GLYOXYLATE_METABOLISM,5,Up,0.556967587190644,0.760758707669339
605,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.558779205530471,0.761971643905187
606,WP_NUCLEAR_RECEPTORS,21,Down,0.562437307091335,0.765193865039548
607,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,49,Down,0.565187149189044,0.765193865039548
608,WP_CIRCADIAN_RHYTHM_GENES,113,Down,0.565610744138725,0.765193865039548
609,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,50,Down,0.565749253617723,0.765193865039548
610,WP_PARKINSONS_DISEASE_PATHWAY,25,Down,0.566969365764286,0.765193865039548
611,WP_MIRNA_BIOGENESIS,6,Down,0.567020137856307,0.765193865039548
612,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Up,0.567634721702065,0.765193865039548
613,WP_PYRIMIDINE_METABOLISM,71,Down,0.57039593052228,0.767661733574031
614,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.573005069517692,0.769917235101133
615,WP_GPR40_PATHWAY,7,Down,0.575462308875068,0.771560242595283
616,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,47,Down,0.576098314471144,0.771560242595283
617,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.578566550676601,0.773610055604856
618,WP_AUTOPHAGY,27,Down,0.581757548601999,0.77661808672597
619,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,42,Down,0.584582566131051,0.779128622064809
620,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.588742328225322,0.782405731583174
621,WP_FOLATE_METABOLISM,36,Down,0.588938132500789,0.782405731583174
622,WP_KLEEFSTRA_SYNDROME,25,Up,0.590104395072687,0.782694736229851
623,WP_VITAMIN_D_METABOLISM,6,Down,0.597512273925609,0.79124819580839
624,WP_NEPHROTIC_SYNDROME,26,Up,0.601327511470426,0.795024354107534
625,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.602858703294144,0.79577348834827
626,WP_KININKALLIKREIN_PATHWAY,2,Down,0.604295512374257,0.796395842985242
627,WP_MEASLES_VIRUS_INFECTION,99,Down,0.610035481912906,0.801512919031794
628,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Up,0.610121349275111,0.801512919031794
629,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.611902644678753,0.801573564732391
630,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.61211072215928,0.801573564732391
631,WP_CILIARY_LANDSCAPE,180,Down,0.613575013628321,0.802217727802479
632,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.616823374014641,0.804563726242564
633,WP_CHOLESTEROL_METABOLISM,49,Down,0.61731980449884,0.804563726242564
634,WP_STEROID_BIOSYNTHESIS,2,Up,0.619340488277649,0.805924136954354
635,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,11,Down,0.62372382367807,0.810349849660485
636,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.627439761518882,0.813895917064587
637,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.629628673198945,0.814181565062797
638,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.629633743648563,0.814181565062797
639,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.635475846638139,0.819684629734784
640,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.635876561248802,0.819684629734784
641,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Up,0.639292427297193,0.81978333503819
642,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.639493082052911,0.81978333503819
643,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.639691107778885,0.81978333503819
644,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.640854894502684,0.81978333503819
645,WP_INTEGRATED_CANCER_PATHWAY,37,Down,0.641494057646314,0.81978333503819
646,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Down,0.642307274168809,0.81978333503819
647,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.64461532444937,0.81978333503819
648,WP_RETT_SYNDROME,30,Down,0.645935410611195,0.81978333503819
649,WP_CHOLESTASIS,9,Up,0.646259003037613,0.81978333503819
650,WP_ADIPOGENESIS,80,Down,0.646335235695976,0.81978333503819
651,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.647374962919375,0.81978333503819
652,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.647877253872606,0.81978333503819
653,WP_KALLMANN_SYNDROME,11,Down,0.649418389404043,0.820039035731262
654,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Down,0.650067308325146,0.820039035731262
655,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.653056477976354,0.822552052412965
656,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.654588770971971,0.823225207396153
657,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.657057508079089,0.824478042058556
658,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.65758369899943,0.824478042058556
659,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.663360742372261,0.829274288531788
660,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.663419430825431,0.829274288531788
661,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,1,Down,0.668207734258492,0.833996037463322
662,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Down,0.67074810578995,0.835902095584152
663,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.671951112277785,0.836138261884121
664,WP_EICOSANOID_SYNTHESIS,13,Down,0.673597667375508,0.836924812627702
665,WP_AMINO_ACID_METABOLISM,57,Up,0.676668023240306,0.839009472103414
666,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.677445169660562,0.839009472103414
667,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,13,Up,0.679221524214522,0.839009472103414
668,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.679908794513705,0.839009472103414
669,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.680360408287496,0.839009472103414
670,WP_IL10_ANTIINFLAMMATORY_SIGNALING,11,Up,0.684836112995471,0.843268348091438
671,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Up,0.686527751561861,0.844091497821961
672,WP_FERROPTOSIS,48,Down,0.687933674736746,0.844561431038416
673,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.694180203466321,0.850963845259606
674,WP_OSTEOCLAST_SIGNALING,9,Down,0.696399475656777,0.852417755811337
675,WP_TRANSSULFURATION_PATHWAY,8,Up,0.703173703380629,0.859434526354102
676,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.70512455464004,0.860355706574265
677,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,268,Down,0.706013107091852,0.860355706574265
678,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.718067330263724,0.87375449478993
679,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,13,Down,0.720655595099529,0.875612468272624
680,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.721809400083469,0.87572463980715
681,WP_ALPHA_6_BETA_4_SIGNALING,24,Up,0.726630428169622,0.877807039046476
682,WP_BENZOAPYRENE_METABOLISM,4,Up,0.726828462946023,0.877807039046476
683,WP_ESTROGEN_METABOLISM_WP697,6,Down,0.727442094024645,0.877807039046476
684,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.728045091349766,0.877807039046476
685,WP_IL9_SIGNALING,15,Down,0.729079093251678,0.877807039046476
686,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.730340540087063,0.877807039046476
687,WP_TYPE_II_DIABETES_MELLITUS,12,Up,0.730973861605974,0.877807039046476
688,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,27,Up,0.732830719810254,0.878757767214331
689,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.734407017488248,0.879369795976494
690,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,40,Up,0.735670525365339,0.879606062936818
691,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.740657832137476,0.88428757093114
692,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.743007239109217,0.885810653562289
693,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,28,Down,0.746182604869643,0.888312624844814
694,WP_SLEEP_REGULATION,10,Up,0.751707981606409,0.893600986779954
695,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,23,Up,0.756911440218296,0.898280733213626
696,WP_OPIOID_RECEPTOR_PATHWAYS,25,Up,0.75782229129295,0.898280733213626
697,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.75999034350507,0.89955815407702
698,WP_CELLULAR_PROTEOSTASIS,6,Up,0.762239367071931,0.900927618673844
699,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,47,Down,0.771994523232474,0.908303969036676
700,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.772453487767359,0.908303969036676
701,WP_ESTROGEN_RECEPTOR_PATHWAY,9,Down,0.772749820578714,0.908303969036676
702,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,4,Down,0.773019921269767,0.908303969036676
703,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.776172557481392,0.908303969036676
704,WP_TGFB_SMAD_SIGNALING,6,Down,0.776430734340831,0.908303969036676
705,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Up,0.776807833695334,0.908303969036676
706,WP_METHYLATION_PATHWAYS,5,Up,0.77728800259381,0.908303969036676
707,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.780507990799856,0.908778835109965
708,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.781455573072571,0.908778835109965
709,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.784701087543753,0.908778835109965
710,WP_LEPTININSULIN_SIGNALING_OVERLAP,12,Down,0.786302665955278,0.908778835109965
711,WP_ETHER_LIPID_BIOSYNTHESIS,15,Up,0.786738396460541,0.908778835109965
712,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.787620997630679,0.908778835109965
713,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.789228632823881,0.908778835109965
714,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,20,Up,0.789596529987445,0.908778835109965
715,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,64,Down,0.789616337397395,0.908778835109965
716,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,128,Up,0.789667864346316,0.908778835109965
717,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Down,0.789811423968297,0.908778835109965
718,WP_PRIMARY_OVARIAN_INSUFFICIENCY,87,Down,0.791066818416933,0.908955606119735
719,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.796293844349153,0.913689042542491
720,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.801734293796053,0.917092267772318
721,WP_MTHFR_DEFICIENCY,18,Down,0.801742724613213,0.917092267772318
722,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Down,0.802594687674683,0.917092267772318
723,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,11,Up,0.812202339867272,0.924145280355118
724,WP_OXIDATION_BY_CYTOCHROME_P450,16,Down,0.815093866450724,0.924145280355118
725,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.816681388663112,0.924145280355118
726,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,16,Down,0.816822868311184,0.924145280355118
727,WP_TCA_CYCLE_IN_SENESCENCE,9,Down,0.816962691564201,0.924145280355118
728,WP_IRON_METABOLISM_DISORDERS,12,Down,0.817440975861685,0.924145280355118
729,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.817728551102105,0.924145280355118
730,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.817728551102105,0.924145280355118
731,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.821305532258284,0.926328666703337
732,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.821906162456779,0.926328666703337
733,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.832182486283441,0.933072142186489
734,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.832861468840642,0.933072142186489
735,WP_PDGFRBETA_PATHWAY,27,Down,0.833135288178734,0.933072142186489
736,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.83488539155792,0.933072142186489
737,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,18,Down,0.83640776311608,0.933072142186489
738,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.836658079239825,0.933072142186489
739,WP_SELENIUM_MICRONUTRIENT_NETWORK,50,Down,0.837535270791448,0.933072142186489
740,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.839080239123198,0.933072142186489
741,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.839226958072214,0.933072142186489
742,WP_HIPPOYAP_SIGNALING,15,Down,0.839512553668029,0.933072142186489
743,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.841412746490335,0.933072142186489
744,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.841461422771816,0.933072142186489
745,WP_FOXA2_PATHWAY,9,Up,0.844673359602464,0.935376539157091
746,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.846615096550125,0.935936415850158
747,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Down,0.847447881987962,0.935936415850158
748,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.848704151377054,0.93607075519528
749,WP_VITAMIN_B12_DISORDERS,9,Up,0.853293062599612,0.939875536241228
750,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.855418530246294,0.940960383270923
751,WP_NPHP1_DELETION_SYNDROME,10,Down,0.857435586080553,0.940970285669799
752,WP_5Q35_COPY_NUMBER_VARIATION,75,Down,0.858215774733021,0.940970285669799
753,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.858849242556798,0.940970285669799
754,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Down,0.862017524832949,0.942871426522635
755,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,36,Up,0.86744892354422,0.942871426522635
756,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.868242184876624,0.942871426522635
757,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Down,0.868528283301073,0.942871426522635
758,WP_COPPER_HOMEOSTASIS,39,Up,0.869317701186758,0.942871426522635
759,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,12,Up,0.870527438857383,0.942871426522635
760,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Down,0.873362043454176,0.942871426522635
761,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.873879274035672,0.942871426522635
762,WP_FOXP3_IN_COVID19,9,Down,0.874006453262589,0.942871426522635
763,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.876072749333155,0.942871426522635
764,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.876371260697004,0.942871426522635
765,WP_PPARALPHA_PATHWAY,15,Up,0.877752843036892,0.942871426522635
766,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,10,Up,0.878352738237306,0.942871426522635
767,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.878562633536955,0.942871426522635
768,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Down,0.878678448956528,0.942871426522635
769,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.8798641095776,0.942871426522635
770,WP_WHITE_FAT_CELL_DIFFERENTIATION,22,Down,0.880013331421126,0.942871426522635
771,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,20,Down,0.881445430855817,0.943164533947035
772,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.882573357826801,0.943164533947035
773,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,69,Down,0.883893525840107,0.943353374926376
774,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.887975848164709,0.945416066860783
775,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.888118123414675,0.945416066860783
776,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.893308110023592,0.946935922709494
777,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,14,Up,0.894048362459812,0.946935922709494
778,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.89406432004155,0.946935922709494
779,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.895200197431897,0.946935922709494
780,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Down,0.896360876672803,0.946935922709494
781,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.896810891813878,0.946935922709494
782,WP_RETINOBLASTOMA_GENE_IN_CANCER,65,Down,0.898104707353571,0.946935922709494
783,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.899278901005055,0.946935922709494
784,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,16,Up,0.899876076853628,0.946935922709494
785,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.903414448015044,0.94944830523874
786,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,19,Down,0.905499330394461,0.950428686482736
787,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Up,0.912408832586906,0.95528912311298
788,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Down,0.913503301792656,0.95528912311298
789,WP_GLUCOCORTICOID_BIOSYNTHESIS,3,Up,0.913871009781795,0.95528912311298
790,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.914761705768793,0.95528912311298
791,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,1,Down,0.917134620449287,0.956556336119673
792,WP_BENZENE_METABOLISM,3,Down,0.919612564148798,0.957163051216964
793,WP_NRF2_PATHWAY,69,Up,0.921138318456204,0.957163051216964
794,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,8,Up,0.921196924443963,0.957163051216964
795,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.92396694580269,0.957761273364201
796,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.924094513452005,0.957761273364201
797,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.927734505262708,0.960327436438813
798,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.934745444266969,0.966372169824874
799,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.937777282952966,0.968293189532161
800,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.940919917038791,0.970323664446253
801,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Up,0.942472628793952,0.970711509057441
802,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.945333323457208,0.971293730185158
803,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.945392564046887,0.971293730185158
804,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,9,Down,0.949542388413958,0.974343868708352
805,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.95236456487869,0.974667984735744
806,WP_HEME_BIOSYNTHESIS,8,Down,0.95236456487869,0.974667984735744
807,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Up,0.954500087580481,0.974667984735744
808,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,60,Down,0.954583917171492,0.974667984735744
809,WP_SPINA_BIFIDA,10,Up,0.961960576977995,0.980551544695004
810,WP_ZINC_HOMEOSTASIS,20,Down,0.962723334791459,0.980551544695004
811,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,11,Down,0.967108224674183,0.982234919558065
812,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.967718837358094,0.982234919558065
813,WP_SULFATASE_AND_AROMATASE_PATHWAY,3,Down,0.967947866182675,0.982234919558065
814,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.971122113624215,0.984245385429947
815,WP_CORI_CYCLE,11,Up,0.974835765175157,0.986796940207981
816,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,2,Up,0.97884766520972,0.987718872616625
817,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.97884766520972,0.987718872616625
818,WP_ALSTROM_SYNDROME,26,Down,0.979338227636847,0.987718872616625
819,WP_BASE_EXCISION_REPAIR,29,Down,0.982551137826251,0.989749314660143
820,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,20,Up,0.984174375883819,0.990175439151403
821,WP_ONECARBON_METABOLISM,22,Down,0.99000695744101,0.993926378774022
822,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.990312101033026,0.993926378774022
823,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Up,0.99288092231737,0.995293755664435
824,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,14,Up,0.994593849979677,0.995800881351012
825,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.998655712264555,0.998655712264555
